LERGYPAX Orodispersible tab B/40

Allium cepa 6 DH ..................................................................................................................................... 5,000 mg

Euphrasia officinalis 2 DH ........................................................................................................................ 5,000 mg

Histaminum 6 DH ..................................................................................................................................... 5,000 mg

Sabadilla 6 DH ......................................................................................................................................... 5,000 mg

Arsenicum iodatum 6 DH ......................................................................................................................... 5,000 mg

Arundo donax 2 DH .................................................................................................................................. 5,000 mg

For one tablet of 250 mg.

Excipient with known effect: lactose. One tablet contains 134,25 mg of lactose.

Homeopathic medicine traditionally used as adjunctive treatment of certain allergic manifestations: spasmodic rhinitis (periodic or aperiodic), hay fever, allergic conjunctivitis.

Dosage

Medicine reserved for adults and children over 30 months.

As prevention: 2 tablets 2 times a day, the month before and throughout the seasonal allergy period.

In case of crisis: 2 tablets 5 times a day for 3 days, then 2 tablets 3 times a day for 8 days, then 2 tablets 2 times a day throughout the exposure period.

Method of administration

Sublingual route.

Allow the tablet to dissolve under the tongue, away from meals.

In children from 30 months to 6 years: dissolve the tablet in a little water before administration, due to the risk of choking.

• Children under 30 months.
• Hypersensitivity to the active substances or to any of the excipients listed in section Composition.

This medicinal product contains lactose. Its use is not recommended in patients with galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption syndrome (rare hereditary disorders).

In the absence of experimental and clinical data, and as a precautionary measure, use of this medicine should be avoided during pregnancy and breastfeeding.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres - Website: www.ansm.sante.fr.

Sas object.

Pharmacotherapeutic class: homeopathic medicine.

In the absence of scientific data, the indication of this medicine is based on the traditional homeopathic use of its components.

5 years.

Store at a temperature not exceeding 30 °C.

No special requirements.